Cardiovascular Diseases. World Health Organization, accessed 12/03/2023. https://www.who.int/health-topics/cardiovascular-diseases (2023).
Mathur, A., Mohan, V., Ameta, D., Gaurav, B. & Haranahalli, P. Aortic aneurysm. J. Transl. Int. Med. 4, 35–41 (2016).
Phillippi, J. A. On vasa vasorum: A history of advances in understanding the vessels of vessels. Sci. Adv. 8, eabl6364 (2022).
Salmasi, M. Y. et al. Regional variation in biomechanical properties of ascending thoracic aortic aneurysms. Eur. J. Cardiothorac. Surg. 62, ezac392 (2022).
Zhang, C. et al. Aortic stress activates an Adaptive Program in Thoracic Aortic Smooth Muscle Cells That Maintains Aortic Strength and Protects Against Aneurysm and Dissection in Mice. Arterioscler Thromb. Vasc. Biol. 43, 234–252 (2023).
Milutinovic, A., Zivin, M. & Zorc-Pleskovic, R. Differences between inflammatory cells infiltrated into tunica intima, media, and adventitia of ascending aortic aneurysms within diabetic and hypertensive patients. Biomol. Biomed. 23, 596–604 (2023).
Prall, A. K. et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J. Vasc. Surg. 35, 923–929 (2002).
Baxter, B. T. et al. Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial. JAMA 323, 2029–2038, (2020).
Isenburg, J. C., Simionescu, D. T., Starcher, B. C. & Vyavahare, N. R. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 115, 1729–1737 (2007).
Dhital, S. & Vyavahare, N. R. Nanoparticle-based targeted delivery of pentagalloyl glucose reverses elastase-induced abdominal aortic aneurysm and restores aorta to the healthy state in mice. PLoS One 15, e0227165 (2020).
Simionescu, D. et al. Chemical stabilization of the extracellular matrix attenuates growth of experimentally induced abdominal aorta aneurysms in a large animal model. JVS Vasc. Sci. 1, 69–80 (2020).
Kloster, B. O., Lund, L. & Lindholt, J. S. Inhibition of early AAA formation by aortic intraluminal pentagalloyl glucose (PGG) infusion in a novel porcine AAA model. Ann. Med Surg. (Lond.) 7, 65–70 (2016).
Nosoudi, N. et al. Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles. Circ. Res. 117, e80–e89 (2015).
Sinha, A. et al. Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomedicine 10, 1003–1012 (2014).
Cheng, S. W. K. et al. A pilot study to evaluate a novel localized treatment to stabilize small- to medium-sized infrarenal abdominal aortic aneurysms. J. Vasc. Surg. 78, 929–935.e921 (2023).
Blose, K. J. et al. Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression. Regen. Med. 9, 733–741 (2014).
Sharma, A. K. et al. Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation 126, S38–S45 (2012).
Yamawaki-Ogata, A., Oshima, H., Usui, A. & Narita, Y. Bone marrow-derived mesenchymal stromal cells regress aortic aneurysm via the NF-kB, Smad3 and Akt signaling pathways. Cytotherapy 19, 1167–1175 (2017).
Parvizi, M., Petersen, A. H., van Spreuwel-Goossens, C., Kluijtmans, S. & Harmsen, M. C. Perivascular scaffolds loaded with adipose tissue-derived stromal cells attenuate development and progression of abdominal aortic aneurysm in rats. J. Biomed. Mater. Res A 106, 2494–2506 (2018).
Xie, J. et al. Human Adipose-Derived Stem Cells Suppress Elastase-Induced Murine Abdominal Aortic Inflammation and Aneurysm Expansion Through Paracrine Factors. Cell Transpl. 26, 173–189 (2017).
Mulorz, J. et al. peri-Adventitial delivery of smooth muscle cells in porous collagen scaffolds for treatment of experimental abdominal aortic aneurysm. Biomater. Sci. 9, 6903–6914 (2021).
Morrison, J. J. et al. Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care. J. Trauma Acute Care Surg. 87, S44–S47 (2019).
Tsao, C. W. et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation 145, e153–e639 (2022).
Adams, H. P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35–41 (1993).
Tian, B. et al. Clinical and Imaging Indicators of Hemorrhagic Transformation in Acute Ischemic Stroke After Endovascular Thrombectomy. Stroke 53, 1674–1681 (2022).
Liu-Ambrose, T. et al. Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial. JAMA Netw. Open 5, e2236510 (2022).
Kim, H. Y. et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials 243, 119942 (2020).
Guo, L. et al. Enhanced pericyte-endothelial interactions through NO-boosted extracellular vesicles drive revascularization in a mouse model of ischemic injury. Nat. Commun. 14, 7334 (2023).
Liu, X., Geng, X., Shi, Y., Liang, J. & Zhao, L. Biomimetic oxygen-boosted hybrid membrane nanovesicles as the treatment strategy for ischemic stroke with the concept of the neurovascular unit. Biomater. Adv. 148, 213379 (2023).
Ghuman, H. et al. Biodegradation of ECM hydrogel promotes endogenous brain tissue restoration in a rat model of stroke. Acta Biomater. 80, 66–84 (2018).
Wu, Y. et al. Implantation of Brain-Derived Extracellular Matrix Enhances Neurological Recovery after Traumatic Brain Injury. Cell Transpl. 26, 1224–1234 (2017).
Ghuman, H. et al. Long-term retention of ECM hydrogel after implantation into a sub-acute stroke cavity reduces lesion volume. Acta Biomater. 63, 50–63 (2017).
Lee, H. et al. Machine Learning Approach to Identify Stroke Within 4.5 h. Stroke 51, 860–866 (2020).
Hadamitzky, C. et al. Aligned nanofibrillar collagen scaffolds – Guiding lymphangiogenesis for treatment of acquired lymphedema. Biomaterials 102, 259–267 (2016).
Chung, T. K., Gueldner, P. H., Aloziem, O. U., Liang, N. L. & Vorp, D. A. An artificial intelligence based abdominal aortic aneurysm prognosis classifier to predict patient outcomes. Sci. Rep. 14, 3390 (2024).
Inampudi, C., Akintoye, E., Ando, T. & Briasoulis, A. Angiogenesis in peripheral arterial disease. Curr. Opin. Pharm. 39, 60–67 (2018).
Scully, R. E., Arnaoutakis, D. J., DeBord Smith, A., Semel, M. & Nguyen, L. L. Estimated annual health care expenditures in individuals with peripheral arterial disease. J. Vasc. Surg. 67, 558–567 (2018).
Brevetti, G., Giugliano, G., Brevetti, L. & Hiatt, W. R. Inflammation in peripheral artery disease. Circulation 122, 1862–1875 (2010).
Murabito, J. M. et al. Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis 203, 509–514 (2009).
Aday, A. W. & Everett, B. M. Dyslipidemia Profiles in Patients with Peripheral Artery Disease. Curr. Cardiol. Rep. 21, 42 (2019).
Scheller, J., Chalaris, A., Schmidt-Arras, D. & Rose-John, S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys. Acta 1813, 878–888 (2011).
Wolf, J., Rose-John, S. & Garbers, C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 70, 11–20 (2014).
Ley, K. The role of selectins in inflammation and disease. Trends Mol. Med 9, 263–268 (2003).
Signorelli, S. S. et al. Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study. Angiology 67, 870–874 (2016).
Szade, A., Grochot-Przeczek, A., Florczyk, U., Jozkowicz, A. & Dulak, J. Cellular and molecular mechanisms of inflammation-induced angiogenesis. IUBMB Life 67, 145–159 (2015).
Eilken, H. M. & Adams, R. H. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr. Opin. Cell Biol. 22, 617–625 (2010).
Yang, G., Mahadik, B., Choi, J. Y. & Fisher, J. P. Vascularization in tissue engineering: fundamentals and state-of-art. Prog. Biomed. Eng. (Bristol) 2, 012002 (2020).
Li, S., Sengupta, D. & Chien, S. Vascular tissue engineering: from in vitro to in situ. Wiley Interdiscip. Rev. Syst. Biol. Med 6, 61–76 (2014).
Generali, M. et al. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells. Acta Biomater. 97, 333–343 (2019).
Aitsebaomo, J. et al. Recombinant human interleukin-11 treatment enhances collateral vessel growth after femoral artery ligation. Arterioscler Thromb. Vasc. Biol. 31, 306–312 (2011).
Chen, L. et al. The roles of interleukins in perfusion recovery after peripheral arterial disease. Biosci. Rep. 38, BSR20171455 (2018).
Simons, M., Gordon, E. & Claesson-Welsh, L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat. Rev. Mol. Cell Biol. 17, 611–625 (2016).
Cooke, J. P. & Meng, S. Vascular Regeneration in Peripheral Artery Disease. Arterioscler Thromb. Vasc. Biol. 40, 1627–1634 (2020).
Fiedler, U. & Augustin, H. G. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 27, 552–558 (2006).
Levin, M. G. et al. A Missense Variant in the IL-6 Receptor and Protection From Peripheral Artery Disease. Circ. Res 129, 968–970 (2021).
Kang, S. & Kishimoto, T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp. Mol. Med 53, 1116–1123 (2021).
Gopinathan, G. et al. Interleukin-6 Stimulates Defective Angiogenesis. Cancer Res. 75, 3098–3107 (2015).
Zbinden, J. C. et al. Effects of Braiding Parameters on Tissue Engineered Vascular Graft Development. Adv. Health. Mater. 9, e2001093 (2020).
Corradetti, B. et al. Immune tuning scaffold for the local induction of a pro-regenerative environment. Sci. Rep. 7, 17030 (2017).
Lee, J. B. et al. Microchannel network hydrogel induced ischemic blood perfusion connection. Nat. Commun. 11, 615 (2020).
Deveza, L. et al. Polymer-DNA Nanoparticle-Induced CXCR4 Overexpression Improves Stem Cell Engraftment and Tissue Regeneration in a Mouse Hindlimb Ischemia Model. Theranostics 6, 1176–1189 (2016).
Khanna, A., Oropeza, B. P. & Huang, N. F. Engineering Spatiotemporal Control in Vascularized Tissues. Bioeng. (Basel) 9, 555 (2022).
Khanna, A., Zamani, M. & Huang, N. F. Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering. J. Cardiovasc Dev. Dis. 8, 137 (2021).
Mirdamadi, E., Tashman, J. W., Shiwarski, D. J., Palchesko, R. N. & Feinberg, A. W. FRESH 3D Bioprinting a Full-Size Model of the Human Heart. ACS Biomater. Sci. Eng. 6, 6453–6459 (2020).
Hinton, T. J. et al. Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels. Sci. Adv. 1, e1500758 (2015).
Lee, V. K. et al. Creating perfused functional vascular channels using 3D bio-printing technology. Biomaterials 35, 8092–8102 (2014).
Pias, S. C. Pathways of Oxygen Diffusion in Cells and Tissues : Hydrophobic Channeling via Networked Lipids. Adv. Exp. Med Biol. 1232, 183–190 (2020).
Blaeser, A. et al. Controlling Shear Stress in 3D Bioprinting is a Key Factor to Balance Printing Resolution and Stem Cell Integrity. Adv. Health. Mater. 5, 326–333 (2016).
Cooke, M. E. & Rosenzweig, D. H. The rheology of direct and suspended extrusion bioprinting. APL Bioeng. 5, 011502 (2021).
Nesmith, J. E., Chappell, J. C., Cluceru, J. G. & Bautch, V. L. Blood vessel anastomosis is spatially regulated by Flt1 during angiogenesis. Development 144, 889–896 (2017).
Hafa, L. et al. Light Sheet-based Laser Patterning Bioprinting Produces Long-term Viable Full-thickness Skin Constructs. Adv. Mater. 36, e2306258 (2023).
Kawata, S., Sun, H. B., Tanaka, T. & Takada, K. Finer features for functional microdevices. Nature 412, 697–698 (2001).
Urciuolo, A. et al. Intravital three-dimensional bioprinting. Nat. Biomed. Eng. 4, 901–915 (2020).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s42003-024-06567-x